A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression https://www.biorxiv.org/content/10.1101/2023.04.26.538456v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.